NCT02663232View on ClinicalTrials.gov

Study to Analyze Mutations in V600 BRAF Oncogen in Participants With Metastatic Melanoma

CompletedOBSERVATIONAL
Enrollment

264

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions
Metastatic Cancers
Trial Locations (33)

10003

Cáceres

11407

Jerez de la Frontera

12002

Castellon

15006

A Coruña

17007

Girona

18014

Granada

20080

Donostia / San Sebastian

25198

Lleida

28002

Madrid

28007

Madrid

28034

Madrid

28041

Madrid

28046

Madrid

29010

Málaga

30120

Murcia

30202

Cartagena (Murcia)

31008

Pamplona

33011

Oviedo

37007

Salamanca

38010

Santa Cruz de Tenerife

39008

Santander

41009

Seville

41014

Valencia

45004

Toledo

46017

Valencia

48013

Bilbao

50009

Zaragoza

07198

Palma de Mallorca

08003

Barcelona

08035

Barcelona

08036

Barcelona

08916

Barcelona

09006

Burgos

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT02663232 - Study to Analyze Mutations in V600 BRAF Oncogen in Participants With Metastatic Melanoma | Biotech Hunter | Biotech Hunter